5[3]Chastre J,Pagon JY.Ventilator-associated Pneumonia.Am J Respir Crit Care Med,2000,165(2):867～903
6[5]Luna CM,Vujacich P,Niederman M,et al.Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.Chest,1997,111 (3):676 ～ 685
7[6]Iregui M,Ward S,Sherman G,et al.Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.Chest,2002,122 (1):262～268
8[7]Spencer RC.Predominant pathogents found in the European Prevalence of infection in Intensive Care Study.Eur J Clin Microbiol Infect Dis,1996,15(4):281～285
9[8]Alvarez-Lerma F.Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit.Intensive Care Med,1996,22 (5):387 ～ 394
10[9]Grap MJ,Munro CL.Ventilator-associated pneumonia:clinical significance and implications for nurising.Heart Lung,1997,26 (6):419 ～429
